The Advisory Committee on Immunization Practices (ACIP) provides recommendations for the use of quadrivalent human papillomavirus vaccine in both males and females.

Developed By: 

Healthy People 2020 Topic Area: 

Resource Type: 

Tags: 

Reduce Risk or Incidence of Disease or Condition, Healthcare, Public Health, Government & Policymakers, Clinical Practice, Primary Prevention, Patients

Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report, Recommendations and Reports [Internet]; ACIP Recommendations- HPV FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).MMWR 2010;59:626?9. Available from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm